Inhalation Sciences Sweden AB (ISAB)

Currency in SEK
0.15
0.00(-0.68%)
Real-time Data·
Trading near 52-week Low
ISAB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.060.15
52 wk Range
0.060.69
Key Statistics
Bid/Ask
0.12 / 0.14
Prev. Close
0.15
Open
0.06
Day's Range
0.06-0.15
52 wk Range
0.06-0.69
Volume
18.35K
Average Vol. (3m)
151.48K
1-Year Change
-71.4286%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ISAB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Inhalation Sciences Sweden AB Earnings Call Summary for Q2/2026

  • Inhalation Sciences H1 2026 revenue hit 7M SEK, doubling full-year 2025 sales; new orders also doubled year-over-year.
  • Stock flat at $0.14 post-call, near 52-week low of $0.13; shares down 79.7% from $0.69 high amid profitability concerns.
  • Company secured 4M SEK loan facility in July to support operations during ongoing M&A review with PharmaVentures through Nov 2026.
  • Management cited 30M SEK pipeline intact; pursuing U.S. CRO partnerships and leveraging FDA collaboration to drive commercial growth.
  • CEO said company approaching profitability through cost control but provided no specific earnings guidance or timeline for breakeven.
Last Updated: 08/24/2026, 09:14 AM
Read Full Transcript

Earnings

Latest Release
Aug 24, 2026
EPS / Forecast
-0.04 / --
Revenue / Forecast
2.7M / --
EPS Revisions
Last 90 days

ISAB Income Statement

Compare ISAB to Peers and Sector

Metrics to compare
ISAB
Peers
Sector
Relationship
P/E Ratio
−0.9x−0.5x−0.4x
PEG Ratio
−0.020.230.00
Price / Book
1.2x3.4x2.6x
Price / LTM Sales
0.9x3.4x3.1x
Upside (Analyst Target)
-177.4%49.4%
Fair Value Upside
Unlock−5.0%6.8%Unlock

Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research in Sweden. The company offers PreciseInhale, a laboratory system that allows scientists to measure how inhaled particles act in lungs and affect the health; DissolvIt, which enables in vitro simulation of dissolution and absorption of respirable particles in the lung epithelium; XposeALI, a 3D cell exposure module that combines aerosol capability with 3D cell models cultured at an air liquid interface; Nose-only inhalation, a standard method of exposure used in preclinical testing of inhalation drugs, as well as for inhalation toxicity studies in rodents; and intratracheal exposure module, an unique technology delivering aerosol directly to the lungs, bypassing the nose, and to spontaneously breathing rodents. Inhalation Sciences Sweden AB (publ) was incorporated in 2004 and is based in Huddinge, Sweden.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
2.28M4.46%318.37K
Public Companies & Retail Investors
48.92M95.54%6.82M
Total
51.2M100.00%7.14M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Avanza Fonder AB3.17%1,624,591227
Nordnet AB (publ)1.28%657,65192

FAQ

What Is the Inhalation Sciences (ISAB) Stock Price Today?

The Inhalation Sciences stock price today is 0.15 SEK.

What Stock Exchange Does Inhalation Sciences Trade On?

Inhalation Sciences is listed and trades on the Spotlight Stock Market.

What Is the Stock Symbol for Inhalation Sciences?

The stock symbol for Inhalation Sciences is "ISAB."

What Is the Inhalation Sciences Market Cap?

As of today, Inhalation Sciences market cap is 7.68M SEK.

What Is Inhalation Sciences's Earnings Per Share (TTM)?

The Inhalation Sciences EPS (TTM) is -0.20.

When Is the Next Inhalation Sciences Earnings Date?

Inhalation Sciences will release its next earnings report on Nov 23, 2026.

From a Technical Analysis Perspective, Is ISAB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Inhalation Sciences Stock Split?

Inhalation Sciences has split 0 times.

How Many Employees Does Inhalation Sciences Have?

Inhalation Sciences has 5 employees.

What is the current trading status of Inhalation Sciences (ISAB)?

As of Sep 01, 2026, Inhalation Sciences (ISAB) is trading at a price of 0.15 SEK, with a previous close of 0.15 SEK. The stock has fluctuated within a day range of 0.06 SEK to 0.15 SEK, while its 52-week range spans from 0.06 SEK to 0.69 SEK.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.